Frontlight ResearchEarly access
Melanoma trials in Estonia
1 of 1 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in EstoniaNeoadjuvant Darovasertib in Primary Uveal Melanoma
- Where
- Tallinn
- Age
- 18 years and over
- People
- 520 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07015190 · EU 2025-522387-32-00